Crystal Structures of Fumarate Hydratases from Leishmania major in a Complex with Inhibitor 2-Thiomalate

Leishmaniases affect the poorest people on earth and have no effective drug therapy. Here, we present the crystal structure of the mitochondrial isoform of class I fumarate hydratase (FH) from Leishmania major and compare it to the previously determined cytosolic Leishmania major isoform. We further...

Full description

Bibliographic Details
Main Authors: Feliciano, Patricia Rosa (Author), Nonato, M. Cristina (Author), Drennan, Catherine L (Author)
Other Authors: Massachusetts Institute of Technology. Department of Biology (Contributor), Massachusetts Institute of Technology. Department of Chemistry (Contributor)
Format: Article
Language:English
Published: American Chemical Society (ACS), 2020-05-26T13:28:36Z.
Subjects:
Online Access:Get fulltext
LEADER 02514 am a22002773u 4500
001 125441
042 |a dc 
100 1 0 |a Feliciano, Patricia Rosa  |e author 
100 1 0 |a Massachusetts Institute of Technology. Department of Biology  |e contributor 
100 1 0 |a Massachusetts Institute of Technology. Department of Chemistry  |e contributor 
700 1 0 |a Nonato, M. Cristina  |e author 
700 1 0 |a Drennan, Catherine L  |e author 
245 0 0 |a Crystal Structures of Fumarate Hydratases from Leishmania major in a Complex with Inhibitor 2-Thiomalate 
260 |b American Chemical Society (ACS),   |c 2020-05-26T13:28:36Z. 
856 |z Get fulltext  |u https://hdl.handle.net/1721.1/125441 
520 |a Leishmaniases affect the poorest people on earth and have no effective drug therapy. Here, we present the crystal structure of the mitochondrial isoform of class I fumarate hydratase (FH) from Leishmania major and compare it to the previously determined cytosolic Leishmania major isoform. We further describe the mechanism of action of the first class-specific FH inhibitor, 2-thiomalate, through X-ray crystallography and inhibition assays. Our crystal structures of both FH isoforms with inhibitor bound at 2.05 Å resolution and 1.60 Å resolution show high structural similarity. These structures further reveal that the selectivity of 2-thiomalate for class I FHs is due to direct coordination of the inhibitor to the unique Fe of the catalytic [4Fe-4S] cluster that is found in class I parasitic FHs but is absent from class II human FH. These studies provide the structural scaffold in order to exploit class I FHs as potential drug targets against leishmaniases as well as Chagas diseases, sleeping sickness, and malaria. 
520 |a Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2013/14988-8) 
520 |a Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2014/22246-4) 
520 |a Fundação de Amparo à Pesquisa do Estado de São Paulo (Grant 2008/08262-6) 
520 |a National Institute of General Medical Sciences (U.S.) (Grant R35 GM126982) 
520 |a National Institute of General Medical Sciences (U.S.) (Grant P41 GM103403) 
520 |a National Institutes of Health (U.S.). Office of Research Infrastructure Programs. High-End Instrumentation (HEI) Grant Program (Grant S10 RR029205) 
520 |a United States. Department of Energy. Office of Science (Contract DE-AC02-06CH11357) 
546 |a en 
655 7 |a Article 
773 |t ACS chemical biology